• Ebola is 'contained' in Nigeria: Health minister Tuesday, 26 Aug 2014 | 12:05 PM ET
    A pharmacist searches for drugs in a pharmacy in Lagos, Nigeria, July 26, 2014.

    Nigeria's health minister has insisted the Ebola outbreak has been contained in the country.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Ahead of the Bell: Kite Pharma shares jump Tuesday, 26 Aug 2014 | 8:42 AM ET

    Shares of Kite Pharma surged before markets opened Tuesday after the drug developer detailed promising results for its most advanced product, a potential treatment for an aggressive form of non-Hodgkin's lymphoma.

  • Aug 25- Drug developer Kite Pharma Inc said its experimental cancer immunotherapy showed potential in treating patients with an aggressive form of blood cancer, in an early-stage study. In one arm of the study, funded by Kite and conducted by National Cancer Institute, 15 patients were given the therapy.

  • BUZZ-: KITE PHARMA INC: LEAD CANCER DRUG SHOWS PROMISE IN. **Cancer drug developer's shares up 31.2 pct at $29.25 in extended trade. **Says its lead drug has potential to treat aggressive form of blood cancer.

  • Aug 25- Drug developer Kite Pharma Inc said its experimental cancer therapy showed potential in treating patients in an early-stage study. The company's lead drug, KTE-C19, is being developed to fight an aggressive form of blood cancer. Kite's shares were up 35.2 percent at $33.33 in extended trading.

  • WINNIPEG, Manitoba, Aug 25- Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc's technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring.

  • Roche's blockbuster pharma deal     Monday, 25 Aug 2014 | 3:47 PM ET

    CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.

  • Aug 25- Four monkeys survived the Ebola virus after being injected with Immunovaccine Inc's experimental vaccine, the tiny Canadian company said on Monday, an announcement that sent its stock soaring. The tests were performed by the U.S. Health Department's National Institutes of Health, based in Maryland.

  • Roche CEO: InterMune perfect strategic fit     Monday, 25 Aug 2014 | 11:18 AM ET

    CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.

  • FDA names potential Insys treatment an orphan drug Monday, 25 Aug 2014 | 10:17 AM ET

    A potential treatment from Insys Therapeutics Inc. for an aggressive form of brain cancer will have some marketing exclusivity if regulators eventually approve it. The Food and Drug Administration has granted an orphan drug designation to the Chandler, Arizona, drugmaker's pharmaceutical cannabidiol, or CBD.

  • LOS ANGELES, Aug 25- U.S. regulators are likely to approve Merck& Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.

  • British Ebola patient to be evacuated: Official Sunday, 24 Aug 2014 | 4:05 AM ET

    The first British citizen confirmed to be infected with the deadly Ebola disease is being evacuated from Sierra Leone.

  • New Obama birth control fixes for religious groups Friday, 22 Aug 2014 | 1:24 PM ET

    WASHINGTON— Seeking to quell a politically charged controversy, the Obama administration announced new measures Friday to allow religious nonprofits and some companies to opt out of paying for birth control for female employees while still ensuring those employees have access to contraception.

  • Ebola outbreak revives interest in 'The Hot Zone' Friday, 22 Aug 2014 | 1:19 PM ET

    NEW YORK— The current Ebola outbreak has revived interest in a 1994 book about the deadly virus: Richard Preston's " The Hot Zone." "The Hot Zone" is subtitled "a terrifying true story. Hundreds have died from the latest outbreak, which has been reported in Nigeria, Guinea, Sierra Leone and Liberia.

  • A look at this week's ice bucket challenges to raise awareness and donations for the ALS Association. Watch Rod Stewart and Rudy Gay dump Vivek Ranadivé, Chris Mullin, and Sunil Gulati.

  • ATLANTA, Aug 21- Appearing thin but smiling, a Texas doctor who weeks ago entered an Atlanta hospital in a full-body biohazard suit to be treated for Ebola said on Thursday he was "thrilled to be alive" as doctors declared him virus-free and safe for release.

  • ATLANTA, Aug 21- Two American aid workers who just weeks ago were gravely ill with Ebola they contracted in Liberia now pose no health risk to the public after being cleared of the virus and released from an Atlanta hospital, one of their doctors said on Thursday.

  • ATLANTA, Aug 21- Two American aid workers discharged from an Atlanta hospital after being treated for Ebola pose no health risk to the public, an Emory University Hospital doctor said on Thursday.

  • New restrictions on hydrocodone to take effect Thursday, 21 Aug 2014 | 11:06 AM ET

    The move, announced in a federal notice, comes more than a decade after the Drug Enforcement Administration first recommended reclassifying hydrocodone due to its risks for abuse and addiction. But last year the FDA changed its position, citing the national epidemic of overdoses and deaths tied to prescription painkillers known as opioids.